Crinetics Pharmaceuticals Inc.

06/22/2026 | Press release | Distributed by Public on 06/22/2026 14:17

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.
The annual meeting of stockholders of Crinetics Pharmaceuticals, Inc. (the "Company") was held online via live audio webcast on June 18, 2026 (the "Annual Meeting"). At the Annual Meeting, there were present, virtually or by proxy, holders of 102,030,415 shares of common stock, or approximately 97% of the total outstanding shares eligible to be voted. The final voting results with respect to each proposal presented at the Annual Meeting are as follows:
Proposal One - Election of Directors
The Company's stockholders approved the election of three Class II directors to the Board of Directors for three-year terms to expire at the 2029 annual meeting of stockholders. The results of such vote were:
Votes For Votes Withheld Broker Non-Votes
Caren Deardorf 73,454,076 23,532,328 5,044,011
Weston Nichols, Ph.D. 90,208,564 6,777,840 5,044,011
Stephanie S. Okey, M.S. 72,225,313 24,761,091 5,044,011
Proposal Two - Ratification of Selection of Independent Registered Public Accounting Firm
The Company's stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of such vote were:
Votes For Votes Against Abstentions
101,675,974 341,727 12,714
Proposal Three - Approval, on an advisory basis, of the compensation of the Company's named executive officers
The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers. The results of such vote were:
Votes For Votes Against Abstentions Broker Non-Votes
91,657,992 2,698,538 2,629,874 5,044,011
Crinetics Pharmaceuticals Inc. published this content on June 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 22, 2026 at 20:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]